![Ilan Zipkin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ilan Zipkin
Directeur/Bestuurslid bij
Via Nova Therapeutics, Inc.
Profiel
Ilan Zipkin currently works at Via Nova Therapeutics, Inc., as Director.
Dr. Zipkin also formerly worked at Versanis Bio, Inc., as Co-Chief Executive Officer, Anteris Bio, Inc., as President & Chief Executive Officer, Tempero Bio, Inc., as Chief Executive Officer, Satori Pharmaceuticals, Inc., as Director, Chimeros, Inc., as Director, Alvine Pharmaceuticals, Inc., as Director, Bioniz Therapeutics, Inc., as Director, Takeda Ventures, Inc., as Senior Investment Director from 2000 to 2017, Quince Therapeutics, Inc., as Director, MPM BioImpact LLC, as Principal, and Prospect Venture Partners, as Partner.
Dr. Zipkin received his undergraduate degree from the University of California, Berkeley and doctorate degree from The University of California, San Francisco.
Actieve functies van Ilan Zipkin
| Bedrijven | Functie | Begin |
|---|---|---|
Via Nova Therapeutics, Inc.
 Via Nova Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for acute and sub acute viral infections | Directeur/Bestuurslid | - |
Eerdere bekende functies van Ilan Zipkin
| Bedrijven | Functie | Einde |
|---|---|---|
Takeda Ventures, Inc.
 Takeda Ventures, Inc. Investment ManagersFinance Takeda Ventures invests in companies located across the globe. The firm focuses on high-caliber, therapeutic, platform-based companies. It provides financing for early stage capital requirements. | Private Equity Investor | 01-06-2017 |
Chimeros, Inc.
 Chimeros, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for cancer treatment | Directeur/Bestuurslid | 09-01-2014 |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Private Equity Investor | 01-06-2005 |
Anteris Bio, Inc.
 Anteris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of renal disease | Algemeen Directeur | - |
Tempero Bio, Inc.
 Tempero Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops treatments for substance use disorders and related conditions | Algemeen Directeur | - |
Opleiding van Ilan Zipkin
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
7
Eerstegraads connecties
14
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 14 |
|---|---|
Satori Pharmaceuticals, Inc.
 Satori Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for alzheimer's disease | Health Technology |
Chimeros, Inc.
Chimeros, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for cancer treatment | Health Technology |
Alvine Pharmaceuticals, Inc.
 Alvine Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and commercializes therapeutics for inflammatory diseases | Health Technology |
Bioniz Therapeutics, Inc.
 Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage biotechnology company | Commercial Services |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prospect Venture Partners
 Prospect Venture Partners Investment ManagersFinance Prospect Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and biomedical innovation sectors. It provides financing for seed, early and growth stage capital requirements. | Finance |
Takeda Ventures, Inc.
Takeda Ventures, Inc. Investment ManagersFinance Takeda Ventures invests in companies located across the globe. The firm focuses on high-caliber, therapeutic, platform-based companies. It provides financing for early stage capital requirements. | Finance |
Quince Therapeutics, Inc.
 Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
Tempero Bio, Inc.
Tempero Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops treatments for substance use disorders and related conditions | Health Technology |
Versanis Bio, Inc.
 Versanis Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Via Nova Therapeutics, Inc.
Via Nova Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for acute and sub acute viral infections | Health Technology |
Anteris Bio, Inc.
Anteris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of renal disease | Health Technology |
